DOCS News
TEM vs. DOCS: Which Medical Info Systems Stock Is the Better Pick Now?
Tempus AI or Doximity: Which medical information systems stock offers better value? Compare growth prospects, AI expansion, earnings estimates and valuation.
Zacks
TEM vs. DOCS: Which Medical Info Systems Stock Is the Better Pick Now?
Tempus AI or Doximity: Which medical information systems stock offers better value? Compare growth prospects, AI expansion, earnings estimates and valuation.
Zacks
Doximity (DOCS) Registers a Bigger Fall Than the Market: Important Facts to Note
Doximity (DOCS) closed the most recent trading day at $33.63, moving 1.81% from the previous trading session.
Zacks
What's Next for Doximity, Inc. Shareholders After 23% Stock Drop? Glancy Prongay Wolke & Rotter LLP Explains Securities Fraud Class Action Lead Plaintiff Deadline
What's Next for Doximity, Inc. Shareholders After 23% Stock Drop? Glancy Prongay Wolke & Rotter LLP Explains Securities Fraud Class Action Lead Plaintiff Deadline What's Next for Doximity, Inc. Shareholders After 23% Stock Drop? Glancy Prongay Wolke & Rotter LLP Explains Securities Fraud Class...
PR Newswire
DOCS DEADLINE: SueWallSt Reminds Doximity, Inc. Investors of Upcoming Securities Class Action Deadline
DOCS DEADLINE: SueWallSt Reminds Doximity, Inc. Investors of Upcoming Securities Class Action Deadline DOCS DEADLINE: SueWallSt Reminds Doximity, Inc. Investors of Upcoming Securities Class Action DeadlinePR NewswireNEW YORK, Oct. 29, 2026 Doximity's CEO and former CFO are named as alleged...
PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Doximity, Inc. of Class Action Lawsuit and Upcoming Deadlines - DOCS
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Doximity, Inc. of Class Action Lawsuit and Upcoming Deadlines - DOCS INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Doximity, Inc. of Class Action Lawsuit and Upcoming...
PR Newswire
Doximity Launches DoseCheck to Catch Dangerous AI Drug Dosing Errors Before They Reach Doctors
Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, has launched DoseCheck, a free additional safety layer in Doximity Ask that instantly checks every AI-generated medication dosing claim against a structured drug database to reduce treatment errors and...
Business Wire
DOCS Shareholder Alert: Doximity, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky
DOCS Shareholder Alert: Doximity, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky DOCS Shareholder Alert: Doximity, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & KorsinskyPR NewswireNEW YORK, Oct. 28, 2026 Wall Street...
PR Newswire
What Does Doximity, Inc.'s 23% Stock Drop Mean for Investors? The Law Offices of Howard G. Smith Outlines Securities Fraud Class Action Lead Plaintiff Deadline
What Does Doximity, Inc.'s 23% Stock Drop Mean for Investors? The Law Offices of Howard G. Smith Outlines Securities Fraud Class Action Lead Plaintiff Deadline What Does Doximity, Inc.'s 23% Stock Drop Mean for Investors? The Law Offices of Howard G. Smith Outlines Securities Fraud Class Action...
PR Newswire
What Should Doximity, Inc. Investors Know After 23% Stock Drop? The Law Offices of Frank R. Cruz Outlines Securities Fraud Class Action Lead Plaintiff Deadline
What Should Doximity, Inc. Investors Know After 23% Stock Drop? The Law Offices of Frank R. Cruz Outlines Securities Fraud Class Action Lead Plaintiff Deadline What Should Doximity, Inc. Investors Know After 23% Stock Drop? The Law Offices of Frank R. Cruz Outlines Securities Fraud Class Action...
PR Newswire
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud LawsuitPR NewswireNEW YORK, Oct. 26, 2026 NEW YORK, Oct. 26, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds...
PR Newswire